Literature DB >> 24379004

An in vitro model to study immune responses of human peripheral blood mononuclear cells to human respiratory syncytial virus infection.

Marloes Vissers1, Marrit N Habets, Inge M L Ahout, Jop Jans, Marien I de Jonge, Dimitri A Diavatopoulos, Gerben Ferwerda.   

Abstract

Human respiratory syncytial virus (HRSV) infections present a broad spectrum of disease severity, ranging from mild infections to life-threatening bronchiolitis. An important part of the pathogenesis of severe disease is an enhanced immune response leading to immunopathology. Here, we describe a protocol used to investigate the immune response of human immune cells to an HRSV infection. First, we describe methods used for culturing, purification and quantification of HRSV. Subsequently, we describe a human in vitro model in which peripheral blood mononuclear cells (PBMCs) are stimulated with live HRSV. This model system can be used to study multiple parameters that may contribute to disease severity, including the innate and adaptive immune response. These responses can be measured at the transcriptional and translational level. Moreover, viral infection of cells can easily be measured using flow cytometry. Taken together, stimulation of PBMC with live HRSV provides a fast and reproducible model system to examine mechanisms involved in HRSV-induced disease.

Entities:  

Mesh:

Year:  2013        PMID: 24379004      PMCID: PMC4047926          DOI: 10.3791/50766

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  17 in total

Review 1.  Respiratory syncytial virus and asthma. The role of monocytes.

Authors:  J L Kimpen
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

Review 2.  Antiviral immune responses and lung inflammation after respiratory syncytial virus infection.

Authors:  Peter J M Openshaw
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity.

Authors:  Mark M Wurfel; William Y Park; Frank Radella; John Ruzinski; Andrew Sandstrom; Jeanna Strout; Roger E Bumgarner; Thomas R Martin
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

4.  Defective interfering particles of respiratory syncytial virus.

Authors:  M W Treuhaft; M O Beem
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

5.  Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein.

Authors:  Anu Cherukuri; Kathryn Patton; Robert A Gasser; Fengrong Zuo; Jennifer Woo; Mark T Esser; Roderick S Tang
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

Review 6.  The interaction of neutrophils with respiratory epithelial cells in viral infection.

Authors:  S Z Wang; K D Forsyth
Journal:  Respirology       Date:  2000-03       Impact factor: 6.424

7.  Respiratory syncytial virus infection in elderly and high-risk adults.

Authors:  Ann R Falsey; Patricia A Hennessey; Maria A Formica; Christopher Cox; Edward E Walsh
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

Review 8.  Immune responses and disease enhancement during respiratory syncytial virus infection.

Authors:  Peter J M Openshaw; John S Tregoning
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

9.  TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide.

Authors:  Meri K Tulic; Robert J Hurrelbrink; Cecilia M Prêle; Ingrid A Laing; John W Upham; Peter Le Souef; Peter D Sly; Patrick G Holt
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

10.  Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans.

Authors:  Steven Kwilas; Rachael M Liesman; Liqun Zhang; Edward Walsh; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

View more
  8 in total

1.  Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels.

Authors:  Marloes Vissers; Inge M L Ahout; Marien I de Jonge; Gerben Ferwerda
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

2.  Recognition of Streptococcus pneumoniae and muramyl dipeptide by NOD2 results in potent induction of MMP-9, which can be controlled by lipopolysaccharide stimulation.

Authors:  Marloes Vissers; Yvonne Hartman; Laszlo Groh; Dirk J de Jong; Marien I de Jonge; Gerben Ferwerda
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

3.  Aptamers for respiratory syncytial virus detection.

Authors:  Krisztina Percze; Zoltán Szakács; Éva Scholz; Judit András; Zsuzsanna Szeitner; Corné H van den Kieboom; Gerben Ferwerda; Marien I de Jonge; Róbert E Gyurcsányi; Tamás Mészáros
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

4.  Vitamin D Induces Differential Effects on Inflammatory Responses During Bacterial and/or Viral Stimulation of Human Peripheral Blood Mononuclear Cells.

Authors:  Jeremy Anderson; Lien Anh Ha Do; Zheng Quan Toh; Edwin Hoe; Andrea Reitsma; Kim Mulholland; Paul V Licciardi
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

5.  Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model.

Authors:  RanLei Wei; Guillem Prats-Ejarque; Lu Lu; Maria Goetz; Gang Wang; Marc Torrent; Ester Boix
Journal:  Cell Mol Life Sci       Date:  2020-11-23       Impact factor: 9.261

6.  Selective cleavage of ncRNA and antiviral activity by RNase2/EDN in THP1-induced macrophages.

Authors:  Lu Lu; Jiarui Li; Ranlei Wei; Irene Guidi; Luca Cozzuto; Julia Ponomarenko; Guillem Prats-Ejarque; Ester Boix
Journal:  Cell Mol Life Sci       Date:  2022-03-26       Impact factor: 9.207

7.  Actin- and clathrin-dependent mechanisms regulate interferon gamma release after stimulation of human immune cells with respiratory syncytial virus.

Authors:  Jop Jans; Hicham elMoussaoui; Ronald de Groot; Marien I de Jonge; Gerben Ferwerda
Journal:  Virol J       Date:  2016-03-22       Impact factor: 4.099

8.  In vitro model for the assessment of human immune responses to subunit RSV vaccines.

Authors:  Tatiana Chirkova; Binh Ha; Bassam H Rimawi; Antonius G P Oomens; Tina V Hartert; Larry J Anderson
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.